More about

Abdominal Pain

News
August 28, 2024
2 min read
Save

Restrictive selection may avoid unnecessary cholecystectomy for abdominal pain, gallstones

Restrictive selection may avoid unnecessary cholecystectomy for abdominal pain, gallstones

Although a restrictive strategy for cholecystectomy reduced the operation rate by 8.3% at 5 years vs. usual care for patients with symptomatic cholelithiasis, the proportion of patients who were pain free did not differ between groups.

Clinical Guidance
Ulcerative Colitis
Presentation and Diagnosis

Clinical Presentation

Gary R. Lichtenstein, MD, FACP, FACG, AGA; Robert B Stein, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News
July 08, 2024
2 min read
Save

Extended tofacitinib use led to ‘complete’ clinical response in refractory celiac disease

Extended tofacitinib use led to ‘complete’ clinical response in refractory celiac disease

Tofacitinib “should be considered as a treatment option” for patients with refractory celiac disease type 2 who previously failed treatment with therapies such as budesonide, according to data in Clinical Gastroenterology and Hepatology.

News
July 01, 2024
2 min read
Save

Select FODMAP reintroduction worsens abdominal pain, bloating in patients with IBS

Select FODMAP reintroduction worsens abdominal pain, bloating in patients with IBS

Reintroduction of fructans and galacto-oligosaccharides was linked to worsened abdominal pain among patients with irritable bowel syndrome who had responded to the low-FODMAP diet, according to research.

News
May 30, 2024
1 min read
Save

Mebeverine not superior to placebo in pediatric IBS; active drug labeling improved efficacy

Mebeverine not superior to placebo in pediatric IBS; active drug labeling improved efficacy

WASHINGTON — Mebeverine was not superior to placebo for the treatment of pediatric irritable bowel syndrome and functional abdominal pain, although active drug labeling significantly improved treatment success, researchers reported.

News
May 23, 2024
2 min read
Save

Hydralazine-induced autoimmune conditions may include drug-induced lupus, vasculitis

Hydralazine-induced autoimmune conditions may include drug-induced lupus, vasculitis

LONG BEACH, Calif. — Hydralazine-induced autoimmune conditions may have a varied presentation, including drug-induced lupus or vasculitis, according to a speaker, here.

News
April 19, 2024
10 min read
Save

Q&A: Delays in endometriosis diagnosis, treatment ‘multifactorial’

Q&A: Delays in endometriosis diagnosis, treatment ‘multifactorial’

Long delays in endometriosis diagnosis are the result of factors spanning from lack of patient and provider awareness to insurance issues. Physicians should consider endometriosis when patients present with abdominal pain, an expert said.

News
April 19, 2024
4 min watch
Save

VIDEO: When it's ‘endometriosis until proven otherwise’

VIDEO: When it's ‘endometriosis until proven otherwise’

Cyclic pain, particularly in the abdomen, that impacts day-to-day life is not normal. Health care providers should always consider endometriosis as a possibility if patients present with such symptoms.

News
April 19, 2024
5 min watch
Save

VIDEO: ‘Normalized’ pain delays endometriosis diagnosis

VIDEO: ‘Normalized’ pain delays endometriosis diagnosis

Delays in endometriosis diagnosis and care may be due to the normalization of female pelvic pain, lack of endometriosis awareness among both patients and providers, and health care access issues.

News
March 27, 2024
2 min read
Save

Rinvoq 45 mg prompts ‘rapid resolution’ of Crohn’s disease symptoms as early as day 5

Rinvoq 45 mg prompts ‘rapid resolution’ of Crohn’s disease symptoms as early as day 5

Once-daily Rinvoq 45 mg provided “rapid relief” of stool frequency and abdominal pain score within the first week of induction therapy in patients with moderately to severely active Crohn’s disease, according to a data analysis.

View more